XML 21 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash flows from operating activities:              
Net earnings $ 1,596 $ 1,032 $ 888 $ 1,293 $ 4,016 $ 3,286  
Adjustments to reconcile net earnings to net cash provided (used) by operating activities:              
Change in receivables and advance premiums         (17) 22  
Capitalization of deferred policy acquisition costs         (770) (778)  
Amortization of deferred policy acquisition costs 268   278   858 869  
Increase in policy liabilities         752 770  
Change in income tax liabilities         (536) 325  
Net investment (gains) losses (199)   171   (885) (224)  
Other, net         (572) (89)  
Net cash provided (used) by operating activities         2,846 4,181  
Proceeds from investments sold or matured:              
Available-for-sale fixed maturity securities         2,997 2,719  
Equity securities         518 210  
Held-to-maturity fixed maturity securities         2 2  
Commercial mortgage and other loans         1,849 2,625  
Costs of investments acquired:              
Available-for-sale fixed maturity securities         (2,961) (4,187)  
Equity securities         (414) (458)  
Commercial mortgage and other loans         (3,552) (3,434)  
Other investments, net         (54) (929)  
Settlement of derivatives, net         (159) 171  
Cash received (pledged or returned) as collateral, net         769 2,123  
Other, net         158 (13)  
Net cash provided (used) by investing activities         (847) (1,171)  
Cash flows from financing activities:              
Purchases of treasury stock         (1,801) (1,676)  
Proceeds from borrowings         1,277 1,153  
Principal payments under debt obligations         (966) (700)  
Dividends paid to shareholders         (740) (647)  
Change in investment-type contracts, net         (61) (25)  
Treasury stock reissued         15 13  
Other, net         20 (15)  
Net cash provided (used) by financing activities         (2,256) (1,897)  
Effect of exchange rate changes on cash and cash equivalents         (84) (46)  
Net change in cash and cash equivalents         (341) 1,067  
Cash and cash equivalents, beginning of period   $ 5,051   $ 5,141 5,051 5,141 $ 5,141
Cash and cash equivalents, end of period $ 4,710   $ 6,208   4,710 6,208 $ 5,051
Supplemental disclosures of cash flow information:              
Income taxes paid         600 478  
Interest paid         153 146  
Noncash interest         17 36  
Noncash financing activities:              
Lease obligations         72 36  
Associate stock bonus              
Treasury stock issued for:              
Treasury stock issued         11 16  
Shareholder dividend reinvestment              
Treasury stock issued for:              
Treasury stock issued         28 23  
Share-based compensation grants              
Treasury stock issued for:              
Treasury stock issued         $ 6 $ 4